I agree, I wasn't happy that insiders sold back last January. I like to give them the benefit of the doubt. Pre clinical, no revenue. They needed some money. That said, 2019 is a put up or shut up year for Inmed. They have a lot of big goals and milestones to hit. If they don't, I will be joining you!